Thrombelastography (TEG) or thromboelastometry (ROTEM) to monitor haemotherapy versus usual care in patients with massive transfusion
A Afshari, A Wikkelsø, J Brok… - … of systematic reviews, 2011 - cochranelibrary.com
A Afshari, A Wikkelsø, J Brok, AM Møller, J Wetterslev
Cochrane database of systematic reviews, 2011•cochranelibrary.comBackground Severe bleeding and coagulopathy as a result of massive transfusion are
serious clinical conditions that are associated with high mortality. Thromboelastography
(TEG) and thromboelastometry (ROTEM) are increasingly used to guide transfusion strategy
but their roles remain disputed. Objectives To systematically assess the benefits and harms
of a TEG or ROTEM guided transfusion strategy in randomized trials involving patients with
severe bleeding.
serious clinical conditions that are associated with high mortality. Thromboelastography
(TEG) and thromboelastometry (ROTEM) are increasingly used to guide transfusion strategy
but their roles remain disputed. Objectives To systematically assess the benefits and harms
of a TEG or ROTEM guided transfusion strategy in randomized trials involving patients with
severe bleeding.
Background
Severe bleeding and coagulopathy as a result of massive transfusion are serious clinical conditions that are associated with high mortality. Thromboelastography (TEG) and thromboelastometry (ROTEM) are increasingly used to guide transfusion strategy but their roles remain disputed.
Objectives
To systematically assess the benefits and harms of a TEG or ROTEM guided transfusion strategy in randomized trials involving patients with severe bleeding.
cochranelibrary.com
以上显示的是最相近的搜索结果。 查看全部搜索结果